MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • MDS Virtual Congress 2020

    TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease

    S. Martinez-Horta, J. Perez-Perez, R. Perez-Gonzalez, A. Horta-Barba, F. Sampedro, E. Rivas-Asensio, T. Xucla, M. Guasch, A. Campolongo, C. Izquierdo-Barrionuevo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore the associations between CSF levels of neurofilament light chain (Nfl), total TAU (tTAU) and phosphorylated TAU (pTAU), structural brain damage and cognitive performance…
  • MDS Virtual Congress 2020

    Automatic classification of abnormal movement in Huntington’s disease using wearable sensors and machine learning

    S. Aradi, R. Pierson, B. Scheid, S. Baldassano, B. Litt, P. Gonzalez-Alegre (Tampa, FL, USA)

    Objective: To integrate wearable sensors into brief clinical assessments and use machine learning to infer HD disease status and predict UHDRS motor subscores for specific…
  • MDS Virtual Congress 2020

    Aceruloplasminemia Presenting as Huntington’s Disease –Look –Alike with Unique MRI Features

    S. Patil, M. Bhatt, A. Aggarwal (Andheri, Mumbai, India)

    Objective: To report case of generalised chorea due to aceruloplasminemia caused by novel mutation in the CP gene Background: Aceruloplasminemia is a type of Neurodegeneration…
  • MDS Virtual Congress 2020

    Detection of Cognitive Changes in Premanifest Huntington’s disease Using the Repeatable Battery for the Assessment of Neuropsychological Status

    A. Mustafa, J. Corey-Bloom, H. Smith, J. Castleton, P. Gilbert (San Diego, CA, USA)

    Objective: The current study is an examination of cognitive changes in premanifest gene carriers for Huntington’s disease (preHD), individuals with manifest Huntington’s disease (HD), and…
  • MDS Virtual Congress 2020

    Efficacy of a Vibrational Armband in Maintenance of Forced Arm Swing in Parkinsonism

    A. Harbour, J. VanWart, Z. Mercer, K. Pique, R. Golan, J. Clark, C. Maitland (Tallahassee, FL, USA)

    Objective: To objectively validate empirical studies regarding the efficacy of a vibratory stimulus on arm swing and fall risk on individuals with Parkinson’s disease (PD).…
  • MDS Virtual Congress 2020

    Case Report: Pseudoatetosis as Manifestation of the Vitamin B12 Deficit

    J. Vargas (Bogotá, Colombia)

    Objective: Subacute combined degeneration (DSAC) of the spinal cord is a classic manifestation in the nervous system of vitamin B12 deficiency, clinically characterized by sensory…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • MDS Virtual Congress 2020

    Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali

    A. Bocoum, S.H Diallo, S. Diallo, A. Koita, Y. Maiga (Bamako, Mali)

    Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…
  • MDS Virtual Congress 2020

    Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

    S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)

    Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
  • MDS Virtual Congress 2020

    Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

    S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)

    Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley